Cite
HARVARD Citation
Lorusso, D. et al. (n.d.). 164 ENGOT-cx11/GOG 3047/KEYNOTE-A18: a phase 3, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer. International journal of gynecological cancer. p. A71. [Online].